Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | OKUROnKure Therapeutics, Inc.FY2024 · Dec |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | — |
| Net income | $59.52M |
| Net income, yoy | −13.0% |
| Net margin | — |
| Free cash flow | $51.87M |
| FCF margin | — |
| EPS, diluted | $4.40 |
Add another company.
No annual figures on file for this.